Holista Colltech Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Holista Colltech Limited with three other
companies in this sector in Australia:
Cellmid Limited
(2018
sales of 5.76 million Australian Dollars [US$3.94 million]
),
Lbt Innovations Limited
(5.96 million Australian Dollars [US$4.08 million]
), and
Immutep Ltd
(7.03 million Australian Dollars [US$4.81 million]
of which 97%
was Cancer Immunotherapy).
Sales Analysis.
Holista Colltech Limited reported sales of A$7.96 million (US$5.44 million)
for the
year ending
December of 2018.
This
represents
an
increase of 5.0%
versus 2017, when the company's sales were A$7.58 million.
Sales at Holista Colltech Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 51%).